MSD

News

MSD, Ionis trumpet lipid-lowering drug data

MSD's enlicitide scores in hypercholesterolaemia, as Ionis lines up broader use for recent approval Tryngolza in severe hypertriglyceridaemia.

News

UK adds chickenpox to childhood vaccination schedule

The UK will offer free vaccination against chickenpox to young children from the start of 2026, in the hope of eliminating cases in a couple of years.

News

NICE backs bladder cancer duo that can double survival

A new treatment regimen for advanced bladder cancer combining MSD's Keytruda with Astellas' Padcev has been given the green light for NHS use.

News

MSD reveals the first details of its job cut plans

MSD's plan to reduce its headcount by around 6,000 looks like it will start at its headquarters in Rahway, New Jersey.

News

MSD trims outlook as it aims to shave $3bn off costs

MSD is embarking on a $3bn cost-reduction drive to prepare for the loss of patent protection for cancer blockbuster Keytruda.

News

MSD, AZ partner LaNova bought by Sino Biopharm for $951m

LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million.

MSD, Ionis trumpet lipid-lowering drug data

UK adds chickenpox to childhood vaccination schedule

NICE backs bladder cancer duo that can double survival

MSD reveals the first details of its job cut plans

MSD trims outlook as it aims to shave $3bn off costs

MSD, AZ partner LaNova bought by Sino Biopharm for $951m

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

MSD

Editor's Picks